Zydax 100 Injection

Pajjiż: New Zealand

Lingwa: Ingliż

Sors: Ministry for Primary Industries

Ingredjent attiv:

sodium pentosan polysulphate

Disponibbli minn:

Parnell Technologies New Zealand Limited

INN (Isem Internazzjonali):

sodium pentosan polysulphate

Kompożizzjoni:

sodium pentosan polysulphate 100 g/litre

Żona terapewtika:

Musculoskeletal modifier

L-istatus ta 'awtorizzazzjoni:

ACVM Registered

Data ta 'l-awtorizzazzjoni:

2009-06-03

Karatteristiċi tal-prodott

100 Injection
100 Injection
100 Injection
READ ENCLOSED LEAFLET
BEFORE USING THIS PRODUCT.
DIRECTIONS FOR USE:
RESTRAINTS:
DO NOT USE in food producing species
of animals.
Contraindicated for use in dogs suffering
from clotting defects, traumatic
haemorrhage, infection, or liver or
kidney failure.
3 mg/kg (1mL/33kg) bodyweight by
SC or IM injection on four occasions 5-7
days apart.
PARNELL AUSTRALIA PTY. LTD.
4/476 Gardeners Road, Alexandria NSW 2015
Store between 2°C and 8°C.(Refrigerate. Do not freeze).
Protect from light. Use within 28 days of first broaching
vial. APVMA Number 57751/20ml/0409
NEW ZEALAND INFORMATION:
RESTRICTED VETERINARY MEDICINE
Registered pursuant to the ACVM Act 1997,
No. A10254. See www.foodsafety.govt.nz
for registration conditions.
Registered to:
PARNELL TECHNOLOGIES NZ PTY. LTD.
PO Box 73160, Auckland International
Airport, Manukau 2150
20 ML
20 ML
20 ML
50243-04
ACTIVE CONSTITUENT:
PENTOSAN POLYSULFATE
SODIUM 100 mg/mL
An aid in the treatment
of non-infectious,
inflammatory joint
disease in dogs.
ACTIVE CONSTITUENT:
PENTOSAN POLYSULFATE
SODIUM 100 mg/mL
An aid in the treatment
of non-infectious,
inflammatory joint
disease in dogs.
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
batch and expiry
PHARMACOLOGY
Pentosan polysulfate (PPS) is a semisynthetic
polysaccharide
with
a
linear
xylan
(pentosan)
backbone. Xylan is a hemicellulose derived from
plant origin by extraction from the cell walls of
hardwoods.
PPS
possesses
anti-inflammatory,
anti-arthritic and chondroprotective activities.
The beneficial effects of pentosan polysulfate in
joint disease are due to the following actions:
1. Anti-inflammatory activity
2. Inhibition of neutrophil migration into the joint
3. Stimulation of hyaluronic acid synthesis by
synovial fibroblasts, resulting in increased
volume and viscosity of synovial fluid
4. Stimulation of proteoglycan synthesis by
chondrocytes
5. Fibrinolytic act